IBPGNET: lung adenocarcinoma recurrence prediction based on neural network interpretability
Briefings in Bioinformatics · 27.03.2024 · 25 (3)
DOI: 10.1093/bib/bbae080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 31.03.2024. Verfasst von Zhanyu Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Re…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangxi Natural Science Foundation, National Key Clinical Specialty Construction Project, Guangxi Key Clinical Specialty Construction Project.
Abstract (Originalsprache)
Lung adenocarcinoma (LUAD) is the most common histologic subtype of lung cancer. Early-stage patients have a 30–50% probability of metastatic recurrence after surgical treatment. Here, we propose a new computational framework, Interpretable Biological Pathway Graph Neural Networks (IBPGNET), based on pathway hierarchy relationships to predict LUAD recurrence and explore the internal regulatory mechanisms of LUAD. IBPGNET can integrate different omics data efficiently and provide global interpretability. In addition, our experimental results show that IBPGNET outperforms other classification methods in 5-fold cross-validation. IBPGNET identified PSMC1 and PSMD11 as genes associated with LUAD recurrence, and their expression levels were significantly higher in LUAD cells than in normal cells. The knockdown of PSMC1 and PSMD11 in LUAD cells increased their sensitivity to afatinib and decreased cell migration, invasion and proliferation. In addition, the cells showed significantly lower EGFR expression, indicating that PSMC1 and PSMD11 may mediate therapeutic sensitivity through EGFR expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China.
- School of computer, Electronic and Information, Guangxi University, Nanning, Guangxi Zhuang Autonomous Region 530021, China.
ORCID-Profile: Qingfeng Chen, Wei Lan, Shikang Li
Förderung
- Guangxi Natural Science Foundation
- National Key Clinical Specialty Construction Project
- Guangxi Key Clinical Specialty Construction Project
- National Natural Science Foundation of China
- Natural Science Foundation of Guangxi
- CAAI-Huawei MindSpore Open Fund
- Natural Science and Technology Innovation Development Foundation of Guangxi University
Zitieren
APA
Xu, Z., Liao, H., Huang, L., Chen, Q., Lan, W., & Li, S. (2024). IBPGNET: lung adenocarcinoma recurrence prediction based on neural network interpretability. Briefings in Bioinformatics, 25(3). https://doi.org/10.1093/bib/bbae080
Vancouver
Xu Z, Liao H, Huang L, Chen Q, Lan W, Li S. IBPGNET: lung adenocarcinoma recurrence prediction based on neural network interpretability. Briefings in Bioinformatics. 2024;25(3). doi:10.1093/bib/bbae080
BibTeX
@article{Xu2024,
author = {Xu, Zhanyu and Liao, Haibo and Huang, Liuliu and Chen, Qingfeng and Lan, Wei and Li, Shikang},
title = {IBPGNET: lung adenocarcinoma recurrence prediction based on neural network interpretability},
journal = {Briefings in Bioinformatics},
year = {2024},
volume = {25},
number = {3},
doi = {10.1093/bib/bbae080}
}
EUVIMED